Grant ID RP190507
Awarded On August 21, 2019
Title Recombinant Antibody Production Core (RAPC)at Science Park
Program Academic Research
Award Mechanism Core Facility Support Awards
Institution/Organization The University of Texas M.D. Anderson Cancer Center
Principal Investigator/Program Director Kevin McBride
Cancer Sites All Sites
Contracted Amount $3,505,385*

*Pending contract negotiation

Lay Summary

Antibodies are commonly used reagents in research, diagnostics and therapeutics. They are specialized proteins, evolved by immune cells to specifically recognize foreign particles (antigens) and bind with high affinity. These properties make antibodies valuable tools in biomedical research and clinical applications. Obtaining antibodies to a desired target (for example a protein made by a tumor cell or invading virus) allows investigators to identify, purify and track targets. However, two major issues have negatively impacted biomedical and research use of antibodies. First, the ability and cost to make quality antibodies against desired targets (such as those that detect a chemical modifi...

Read More